Azitra, Inc. (NYSEAMERICAN:AZTR) Shares Shorted: Short Interest Up 172.3% in October

Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 30th, there was short interest totaling 305,802 shares, a growth of 172.3% from the October 15th total of 112,293 shares. Approximately 5.1% of the shares of the stock are sold short. Based on an average trading volume of 14,623,589 shares, the days-to-cover ratio is currently 0.0 days.

Azitra Stock Down 9.0%

NYSEAMERICAN AZTR traded down $0.06 during trading hours on Friday, hitting $0.61. 80,169 shares of the company’s stock traded hands, compared to its average volume of 8,145,654. Azitra has a 52-week low of $0.52 and a 52-week high of $3.91. The firm’s 50-day moving average is $1.70 and its 200-day moving average is $1.85.

Azitra (NYSEAMERICAN:AZTR – Get Free Report) last released its earnings results on Thursday, November 12th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.04). As a group, sell-side analysts predict that Azitra will post -2.05 EPS for the current fiscal year.

About Azitra

(Get Free Report)

Azitra, Inc. is a biotechnology company developing treatments for skin diseases using live biotherapeutic products based on bacteria that naturally inhabit the skin. Its approach includes engineering skin-associated bacteria to deliver therapeutic proteins directly to the skin. The company’s pipeline includes ATR-12, a candidate being developed for Netherton syndrome, a rare genetic skin disorder, and ATR-04, a candidate intended to address skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitor cancer treatments.

Further Reading

Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.